IQSEC1
protein-codingIQ motif and Sec7 domain ArfGEF 1, the group of IQSEC ArfGEF family
Gene summary
Predicted to enable guanyl-nucleotide exchange factor activity and protein kinase binding activity. Predicted to be involved in several processes, including positive regulation of focal adhesion disassembly; positive regulation of keratinocyte migration; and regulation of postsynaptic neurotransmitter receptor internalization. Located in cytosol and nucleoplasm. Implicated in intellectual developmental disorder with short stature and behavioral abnormalities and lung adenocarcinoma. Biomarker of lung non-small cell carcinoma. [provided by Alliance of Genome Resources, Jun 2026]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~386.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0032870
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0032870
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0019502
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0100038
Submitter: ClinGen
*IQSEC1* was first reported in relation to autosomal recessive complex neurodevelopmental disorder in 2019 (PMID: 31607425). The core phenotype observed in all reported cases includes severe intellectual disability, short stature, speech impairment, facial dysmorphia, and behavioral problems. Four variants (three missense and one frameshift) that have been reported in three probands in two publications (PMIDs: 31607425, 41738068) are included in this curation. Of note, two unrelated probands reported in 2019 with two novel missense variants curated here (PMID: 31607425) are from consanguineous families with affected siblings that have the same clinical phenotype and homozygous *IQSEC1* variants that were identified by exome sequencing. The mechanism of pathogenicity is reported to be loss- or partial loss-of-function. This gene-disease relationship is also supported by experimental evidence, including a mouse model with a conditional *Iqsec1* deletion in neurons that displayed increased dendritic spine density and immature morphology (PMID: 31607425). In summary, there is limited evidence supporting the relationship between *IQSEC1* and complex neurodevelopmental disorder. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Intellectual Disability and Autism GCEP on the meeting date April 21, 2026 (SOP Version 12).
Inheritance Pattern: AR
Disease ID:MONDO:0032870
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0032870
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0032870
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to IQSEC1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001134382.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 50 | 4 | 57 | ||
| missense | 1 | 1 | 208 | 11 | 2 | 223 |
| nonsense | 3 | 3 | ||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | 2 | |||
| splice donor/acceptor (+/-2bp) | 2 | 2 | ||||
| Total | 1 | 2 | 217 | 61 | 6 | 287 |
Highest pathogenic variant AF is 0.000014325487
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001127854.1 | 14 | MANE Select | |
| Ensembl | ENSP00000480301.1 | 14 | MANE Select | |
| RefSeq | NP_001317548.1 | 11 | Standard | |
| RefSeq | NP_001363867.1 | 16 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| iqsec1a | Danio rerio | Structure: vascular lymphangioblast Quality: decreased amount abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Endocytosis - Homo sapiens (human)
- EGF-EGFR Signaling Pathway
- Plexin-D1 Signaling
- Arf6 signaling events
Biological Process
- actin cytoskeleton organization
- regulation of ARF protein signal transduction
- positive regulation of GTPase activity
- positive regulation of keratinocyte migration
- positive regulation of adherens junction organization
Molecular Function
- ARF guanyl-nucleotide exchange factor activity
- protein binding
- lipid binding
Cellular Component
- nucleolus
- cytoplasm
- membrane
- intracellular membrane-bounded organelle
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000273221
- Coding exons
- 14
- Length
- 175899
- Individuals with no LoFs
- 125737
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 9
- Defined
- 125746
- p
- 0.0000358
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.28 | 496 | 661 | 0.750 | 0.0000481 | 6247 |
| Missense (PolyPhen) | 147 | 251.14 | 0.58534 | 2327 | ||
| Synonymous | -0.112 | 294 | 292 | 1.01 | 0.0000220 | 1953 |
| Loss of Function | 5.34 | 4 | 40.8 | 0.0980 | 0.00000208 | 463 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000065 | 0.000062 | rare |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000055 | 0.000054 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000054 | 0.000053 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Guanine nucleotide exchange factor for ARF1 and ARF6 (PubMed:24058294). Guanine nucleotide exchange factor activity is enhanced by lipid binding (PubMed:24058294). Accelerates GTP binding by ARFs of all three classes. Guanine nucleotide exchange protein for ARF6, mediating internalisation of beta-1 integrin. {ECO:0000269|PubMed:11226253, ECO:0000269|PubMed:16461286, ECO:0000269|PubMed:24058294}.;
Recessive Scores
- pRec
- 0.117
Intolerance Scores
- LoFtool
- 0.159
- RVIS EVS
- -1.26
- RVIS percentile EVS
- 5.34
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.207
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |